Real-time enrollment status for this drug:difluoromethylornithine clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 10:53 PM UTC
| NCT Number | NCT04696029 |
| Recruiting Status | Recruiting |
| Condition | DRUG:Difluoromethylornithine |
| Phase | PHASE2 |
| Target Enrollment | 118 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Giselle Sholler |
| Last Updated on CT.gov | August 12, 2026 (Aug 12, 2026) |
As of October 15, 2026: Clinical trial NCT04696029 is currently recruiting participants. This phase2 study for drug:difluoromethylornithine is actively seeking new participants at 25 locations across the United States. The study is sponsored by Giselle Sholler. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04696029 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04696029 was last updated Aug 12, 2026 (August 12, 2026). HelloStudys verifies this status automatically.